Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Yaacov R Lawrence"'
Autor:
Orit Kaidar-Person, Rakefet Yoeli-Ullman, Nir Pillar, Shani Paluch-Shimon, Philip Poortmans, Yaacov R. Lawrence
Publikováno v:
Breast, Vol 62, Iss , Pp 170-178 (2022)
Purpose: Our aim was to determine whether breast cancer survivors are at increased risk of obstetric and maternal complications at time of delivery. Methods: The USA ‘National Inpatient Sample’ database was queried for hospitalizations associated
Externí odkaz:
https://doaj.org/article/7ea0e27a3bdc461a8ec29bbae9fb739c
Autor:
Einat Shacham Shmueli, Yaacov R. Lawrence, Galia Rahav, Amit Itay, Yaniv Lustig, Naama Halpern, Ben Boursi, Ofer Margalit
Publikováno v:
Cancer Reports, Vol 5, Iss 8, Pp n/a-n/a (2022)
Abstract Background and Aim The BNT162b2 COVID‐19 vaccine (Pfizer/BioNTech), given as a two‐dose series, 3 weeks apart, elicits a serological response in 84–98% of patients with cancer, even if administered while undergoing anticancer treatment
Externí odkaz:
https://doaj.org/article/028414edd9754c2b856173d214a35c58
Autor:
Laura A Dawson, Camilla Zimmermann, Aisling Barry, Galia Jacobson, Ronen Fluss, Amira Dany-BenShushan, Talia Golan, Tikva Meron, Marcin Miszczyk, Michael Buckstein, Dayssy Diaz Pardo, Artur Aguiar, Liat Hammer, Adam P Dicker, Maoz Ben-Ailan, Ofir Morag, David Hausner, Zvi Symon, Yaacov R. Lawrence
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction Pancreatic cancer is characterised by severe mid-back and epigastric pain caused by tumour invasion of the coeliac nerve plexus. This pain is often poorly managed with standard treatments. This clinical trial investigates a novel approac
Externí odkaz:
https://doaj.org/article/dbe7bee2a9924507b65a3138dcb82299
Autor:
Sameh Daher, Yaacov R. Lawrence, Elizabeth Dudnik, Ekaterina Hanovich, Damien Urban, Nir Peled, Rossie Navon, Raya Leibowitz, Ariel Hammerman, Erez Battat, Teodor Gottfried, Amir Onn, Jair Bar
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectivesWe aimed to examine clinical data and baseline blood test results as potential predictive biomarkers for benefit from nivolumab, in advanced non-small cell lung cancer patients (NSCLC).Materials and MethodsA chart review was performed of 10
Externí odkaz:
https://doaj.org/article/171b9ab227c94b9bac153fd78663bf00
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-7 (2019)
Abstract Objective Androgen deprivation therapy (ADT) is beneficial for unfavorable intermediate-risk (IR) prostate cancer patients receiving curative radiotherapy (RT). However, for favorable IR patients the latest NCCN guidelines recommends RT alon
Externí odkaz:
https://doaj.org/article/2d6a78da1caf40adab8218a6e7b1a210
Autor:
Ofer Margalit, Shun Yu, Einat Shacham-Shmueli, Gal Strauss, Yu-Xiao Yang, Yaacov R. Lawrence, Kim A. Reiss, Talia Golan, Naama Halpern, Dan Aderka, Bruce Giantonio, Ronac Mamtani, Ben Boursi
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:1703-1708
Current NCCN guidelines exclude the possibility of using single-agent adjuvant chemotherapy in locally advanced gastric adenocarcinoma, while allowing doublet chemotherapy. However, single-agent adjuvant chemotherapy is a valid treatment option in ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e9b3c61b28be5cd699fa1e1de5b7050
https://doi.org/10.1007/s00432-021-03911-0
https://doi.org/10.1007/s00432-021-03911-0
Autor:
Ariel Shimoni-Sebag, Ifat Abramovich, Bella Agranovich, Yaarit Sirovsky, Chani Stossel, Dikla Atias, Maria Raitses-Gurevich, Yulia Glick-Gorman, Ofer Margalit, David Regev, Rotem Tal, Itay Tirosh, Talia Golan, Keren Yizhak, Eyal Gottlieb, Yaacov R. Lawrence
Publikováno v:
Cancer Research. 83:2411-2411
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is remarkably resistant to standard modalities, including radiotherapy (RT). The mechanisms of radiation resistance in general, and pancreatic cancer in particular, are poorly understood. We hypothesiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd9f67820a6240335e0becb442615aa2
https://doi.org/10.1158/1538-7445.am2023-2411
https://doi.org/10.1158/1538-7445.am2023-2411
Introduction: Chemokine (C-X3-C Motif) Receptor 1 (CX3CR1) is present on a subset of the immune cells in the tumor microenvironment (TME) and plays an essential and diverse role in cancer progression. However, its potential function in the irradiated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c58b85dcdbca8e19afb35dcdcb125c38
https://doi.org/10.21203/rs.3.rs-1587525/v1
https://doi.org/10.21203/rs.3.rs-1587525/v1
Autor:
Michal Yalon, Liron Tuval-Kochen, David Castel, Itai Moshe, Inbal Mazal, Osher Cohen, Camila Avivi, Kineret Rosenblatt, Sarit Aviel-Ronen, Ginette Schiby, Joachim Yahalom, Ninette Amariglio, Raphael Pfeffer, Yaacov R Lawrence, Amos Toren, Gideon Rechavi, Shoshana Paglin
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161799 (2016)
[This corrects the article DOI: 10.1371/journal.pone.0155711.].
Externí odkaz:
https://doaj.org/article/53a6bd4b59a64f0c967b0678d62e1ce5
Autor:
Inbal, Greenhouse, Amit, Itay, Miri, Sklair Levy, Yaacov R, Lawrence, Tamar, Katzman, Einav Nili, Gal-Yam
Publikováno v:
Harefuah. 161(2)
The SARS-CoV-2 pandemic presents a challenge to health systems in general and for cancer patients in particular. The hurdles of receiving ongoing medical treatment starting from diagnosis through continuous medical care is exemplified in this case re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a64b3cf7901129a81c1bf13e7c7f8e74
https://pubmed.ncbi.nlm.nih.gov/35195966
https://pubmed.ncbi.nlm.nih.gov/35195966